morning welcome scientific third quarter conference call operator instruction would like introduce moderator call vice president investor relation begin call vice morning thank join call today chairman president chief executive officer senior vice president chief financial officer please note call webcast live archive investor section website thermofisher head news event copy press release third quarter earn available investor section website head financials begin briefly cover safe harbor statement various remark event make company future expectation plan prospect constitute forward look statement purpose safe harbor provision private security litigation reform actual result differ materially indicate forward look statement result various important factor include cause company recent annual report form subsequent quarterly report form file available investor section website head financials file elect update forward look statement point future specifically disclaim obligation even estimate change therefore rely forward look statement represent view date subsequent today also call refer certain financial measure prepare accordance generally accept account principle reconciliation financial measure directly comparable measure available press release third quarter earn also investor section website head financials turn call chairman president chief executive good morning everyone thank join today third quarter call deliver another outstanding quarter achieve exceptional financial performance continue effectively execute growth strategy make scientific even stronger partner customer reflect year three thing stand prove growth strategy power business system drive outstanding financial performance base business perform play lead role industry response continue build trust partner status innovative product expand capability enhance unique customer value proposition give great confidence bright future continue create sustainable value stakeholder detail remark later first recap financials revenue increase billion grow year year adjust operate income third quarter billion adjust operate margin quarter finally increase adjust share another outstanding quarter turn market market condition strong execute deliver another fantastic quarter start pharma biotech continue outstanding performance market growth drive strong market dynamic unique customer value proposition lead role support customer across wide range excite therapeutic area include significant role support vaccine therapy trust partner status earn many year customer continue drive robust growth market broad base strength include bioproduction pharma service bioscience chromatography mass spectrometry business research safety market channel academic government grow single digit quarter good growth bioscience research safety market channel turn industrial apply grow teen particularly strong growth electron microscopy business research safety market channel finally diagnostics healthcare decline performance base business strong drive immunodiagnostics clinical diagnostics transplant diagnostics also execute support customer test need deliver billion revenue quarter versus billion last year move growth strategy provide comment industry lead role pandemic response quarter generate billion response relate revenue surge delta variant strong test demand around world also play meaningful role vaccine therapy generate million quarter activity underlie demand product service offer production development vaccine robust time expect demand transition revenue industry lead response pandemic enable accelerate growth strategy strengthen customer relationship accelerate investment contribute ability raise long term core organic growth guidance communicate recent investor give update growth strategy consist element continuously develop high impact innovative product leverage scale high growth emerge market deliver unique value proposition customer provide example deliver growth strategy start innovation launch number product across business strengthen industry leadership enable customer accelerate scientific breakthrough make world better place genetic science business launch apply absolute digital system first fully integrate digital system feature simplify workflow design provide highly accurate result minute system help advance customer innovation effort area like oncology cell gene therapy chromatography mass spectrometry launch scientific plus triple quadruple mass spectrometer address grow need faster throughput increase sensitivity across range application biopharma apply include clinical research largest molecule toxicology safety environmental analysis also scientific system scientific column design proteomics precision medicine translational research turn second pillar growth strategy continue leverage scale create outstanding experience customer high growth emerge market contribute excellent performance deliver across pacific deliver growth double digit quarter continue build presence capability region quarter open design center south facility feature laboratory educational space instrument support pharmaceutical research manufacture process center help pharma biotech customer advance important work performance across region demonstrate create differentiate experience customer significant investment make market growth third pillar growth strategy customer value proposition continue increase capability capacity even better partner customer help achieve goal faster efficiently mention last quarter execute billion capex year give brief update progress build pharma service capability bring additional capacity online support vaccine therapy production part previously announce strategic partnership limit assume operate responsibility state biologics site site feature highly flexible bioproduction technology include single stainless steel provide pathway development large scale production customer need evolve support grow demand biopharmaceutical industry announce plan open production facility manufacture single technology facility largest site world addition support disease research diagnostic test announce commitment invest government build state facility manufacture pipette facility look north design line scientific carbon neutrality goal investment value proposition demonstrate commitment customer rely essential partner work give brief update capital deployment continue successfully execute discipline strategy capital deployment combination strategic return capital shareholder term super excite acquisition business perform regulatory process track expect close year reminder establish leader attractive high growth clinical research service industry highly complementary service fastest grow market integration plan finance largely complete look forward welcome colleague later year turn guidance update progress make initiative world leader serve science know responsibility industry leadership position make world better place continue advance sustainability social impact initiative quarter commit expand product label include entire cold storage portfolio year label clearly detail environmental impact product empower customer make sustainable choice ultimately help achieve goal environmental stewardship colleague also passionate difference make local site base community action council support number charitable stem education activity throughout year amplify support effort invest additional million foundation science continue support historically black college university deliver accurate test student staff help ensure campus safety ability confidently deliver person learn like review guidance high level take detail press release raise revenue earn guidance full year increase result strong operational performance base business continue strength response revenue raise revenue guidance billion billion would result revenue growth term adjust raise guidance share represent growth year year guidance raise reflect increase outlook core business strong outlook share investor raise full year revenue guidance million billion increase adjust guidance summarize takeaway execute continue growth momentum deliver excellent revenue earn performance business perform continue play lead role pandemic response continue expand trust partner status innovative product expand capability enhance customer value proposition exceptional performance third quarter enable raise outlook year even brighter future hand call chief financial officer senior vice president chief financial mark good morning everyone detail quarter like begin quick reminder definition core business term introduce recent investor core include base business vaccine therapy response revenue post close also include acquisition move detail another excellent quarter provide high level view quarter play versus expectation time last earn call broad base speed versus prior guide revenue billion higher drive million higher test response revenue million higher core business revenue million favorable core last earn call guidance derisk test response revenue additional opportunity support customer test need ready flow benefit exactly total deliver billion test response revenue quarter great strength core business base business organic growth million higher include prior guide also core vaccine therapy response revenue million higher prior guide million quarter actual momentum line business system enable generate excellent pull strong line performance time execute really significant growth investment result adjust higher include prior guide component achievement test response revenue core business base business overall another excellent quarter provide color performance begin earn result press release grow adjust quarter last year line report revenue year year component report revenue increase include organic growth tailwind foreign exchange contribution acquisition mention base business organic growth quarter turn performance geography quarter north flat grow pacific grow double digit grow single digit rest world decline high single digit organic growth rate skew response revenue current prior quarter scale impact pandemic base business prior year since operational performance adjust operate income decrease adjust operate margin basis point lower last year quarter business system enable deliver strong productivity offset unfavorable business ongoing strategic investment across business include investment colleague make support near long term growth look detail total company adjust gross margin quarter come basis point lower last year decrease gross margin similar driver mention adjust operate margin quarter adjust quarter revenue increase basis point total expense approximately million represent growth versus reflect ongoing investment high impact innovation fuel future growth look result line quarter interest expense million million lower last year largely lower average interest rate debt adjust income expense income quarter million million higher mainly change nonoperating adjust rate quarter basis point versus last year benefit plan initiative average dilute share million million lower year year drive share repurchase option dilution turn cash flow balance sheet cash flow performance enable business system continue strong year date cash flow continue operation billion period last year year date free cash flow billion period last year invest billion capital expenditure reflect strong return generate short term investment make long term return million shareholder dividend quarter reflect dividend increase announce quarter issue billion debt part finance acquisition billion cash billion total debt leverage ratio quarter time gross debt adjust time debt basis conclude comment total company performance adjust basis point last year continue generate exceptional return provide color performance four business segment similar last quarter start frame think impact response segment revenue standpoint case past quarter majority response revenue recognize life science solution remainder recognize party product service specialty diagnostics margin standpoint impact differ across segment base scale response revenue different level profitability revenue addition quarter continue make strategic investment across business size investment necessarily align response revenue segment skew report segment margin move segment detail start life science solution report revenue segment increase organic growth quarter deliver strong growth bioproduction bioscience business adjust operate income life science solution decrease adjust operate margin basis point year year quarter positive volume leverage offset strategic investment unfavorable business analytical instrument segment report revenue increase organic growth growth segment quarter drive electron microscopy chromatography mass spectrometry business adjust operate income analytical instrument increase adjust margin basis point year year quarter deliver strong volume pull productivity partially offset strategic investment make across segment turn specialty diagnostics report revenue decrease segment decline organically quarter strong growth immunodiagnostics clinical diagnostics transplant diagnostics business offset lower test revenue versus year quarter adjust operate income decrease quarter adjust operate margin basis point prior year drive positive productivity enable business system offset unfavorable volume strategic investment quarter finally margin product service segment report revenue increase organic growth quarter strong growth business segment adjust operate income segment increase adjust operate margin basis point lower prior year quarter drive good volume pull productivity business system offset strategic investment turn update guidance mention increase full year guidance bank beat maintain prior guidance assumption carry base business vaccine therapy full year number make strong beat raise year reflect continue excellent strength business provide detail start term revenue raise full year guidance billion billion increase full year organic growth outlook increase base business organic growth outlook full year increase response revenue year billion billion represent billion test response revenue billion vaccine therapy response revenue mention previously change revenue assumption revise guidance continue derisked approach guidance test response revenue continue assume million test relate revenue continue range outcome test fourth quarter scenario test demand could higher include guidance case position support customer need flow benefit think prudent continue take derisked approach outlook reminder four fewer sell period last year incorporate strong performance revise guidance expect adjust operate margin full year approximately basis point higher prior guide term adjust bank beat raise full year adjust guidance would result growth revise guidance range adjust income rate slightly higher prior guide reflect marginal rate increase profitability rest assumption underlie guidance remain call include operational benefit acquisition assume close year expect full year interest approximately million assume capital expenditure approximately billion free cash flow approximately billion guidance still include billion capital deployment billion share buyback billion complete million capital return shareholder dividend mean make full year average dilute share count million share move guidance rate mention carry base business vaccine therapy full year number term revenue raise full year guidance million billion reflect million increase core revenue offset partially million tailwind year guidance continue core organic growth million test response revenue year term adjust raise full year guidance mention guidance increase reflect increase strength core business already strong outlook share recent investor conclude deliver another excellent quarter mean great position achieve goal turn call back vice operator ready take question